| Literature DB >> 29379755 |
Christina Andreou1, Brooke C Schneider1, Ryan Balzan2, Daniel Luedecke1, Daniela Roesch-Ely3, Steffen Moritz1.
Abstract
Patients with delusions exhibit an increased tendency to arrive at decisions based on very limited evidence (jumping-to-conclusions; JTC), making this reasoning bias relevant for the treatment of delusions. Neurocognitive deficits contribute to JTC, but it is not known whether this has any bearing on the clinical syndrome of delusions. We addressed this question by reanalyzing data from an efficacy study of non-pharmacological interventions as adjunctive treatments in schizophrenia. We investigated the longitudinal associations of cognitive functioning, JTC and delusions in patients with psychotic disorders receiving either a metacognitive intervention addressing reasoning biases (n = 59), or cognitive remediation (n = 58). Both interventions improved JTC; in the cognitive remediation group, tentative evidence suggested that better neurocognitive performance contributed to this improvement. However, JTC gains were associated with delusion improvement only in the metacognitive intervention group, suggesting a content-specific mechanism of action.Entities:
Keywords: Cognitive biases; Cognitive remediation; Delusions; Metacognitive training; Schizophrenia
Year: 2015 PMID: 29379755 PMCID: PMC5779293 DOI: 10.1016/j.scog.2015.02.001
Source DB: PubMed Journal: Schizophr Res Cogn ISSN: 2215-0013
Mean scores and standard deviations (SD) for variables of interest at baseline and at the 6-month follow-up for each group separately.
| MCT (n = 59) | CogPack® (n = 58) | |||||||
|---|---|---|---|---|---|---|---|---|
| Baseline | Follow up | Baseline | Follow-up | |||||
| PANSS delusion subscore | 8.05 | (3.9) | 6.08 | (3.3) | 7.78 | (3.6) | 6.83 | (3.5) |
| Fish Task (number of draws to decision) | 2.68 | (2.0) | 3.83 | (2.2) | 2.86 | (2.4) | 3.66 | (2.6) |
| Trail-Making Test B (s) | 82.78 | (38.3) | 73.20 | (36.1) | 68.26 | (29.1) | 58.91 | (25.4) |
Note: In contrast to Table 2 in Moritz et al. (2013), scores are only presented for patients for whom both baseline and follow-up scores were available for all measures of interest (missing data in n = 4 patients).
RBMT: Rivermead Behavioural Learning Test; PANSS: Positive and Negative Syndrome Scale.
p < 0.05 compared to baseline.
p < 0.01 compared to baseline.
p < 0.001 compared to baseline.
Fig. 1Correlation between change in performance on the Trail Making Test, part B (TMT-B) and changes in evidence gathering from baseline to the 6-month follow-up in the two treatment groups. Continuous regression line: MCT group; dotted regression line: CogPack group.
Fig. 2Relationship between change in evidence gathering performance and change in delusions from baseline to the 6-month follow-up in the two treatment groups. Continuous regression line: MCT group; dotted regression line: CogPack® group.